Speech Sound Stimulation for Stuttering
Trial Summary
What is the purpose of this trial?
The purpose of this research study is to understand how speech and language are processed in the brain. This study will provide information that may help with the understanding how speech and language are processed in children and whether there may be differences between children who stutter and children who do not stutter. This project will evaluate these neural processes for speech signals in children who stutter and control subjects through a battery of behavioral speech and language tests, electroencephalography-based (EEG) tasks, functional magnetic resonance imaging (fMRI), and computational modeling.
Will I have to stop taking my current medications?
If you are taking medication that alters brain function, you will need to stop taking it to participate in this trial.
What data supports the effectiveness of the treatment Speech sound stimulation for stuttering?
Research shows that altered auditory feedback (AAF), which includes delayed auditory feedback (DAF), can help improve speech fluency in people who stutter. Studies indicate that these devices are perceived as effective by users and have shown positive results in controlled environments, although more research is needed for everyday speaking situations.12345
Is speech sound stimulation safe for humans?
How does the Speech Sound Stimulation treatment for stuttering differ from other treatments?
The Speech Sound Stimulation treatment for stuttering is unique because it uses altered auditory feedback (AAF), such as delayed auditory feedback (DAF) and frequency-altered feedback (FAF), to enhance fluency. This approach differs from traditional speech therapy by providing real-time auditory modifications that help reduce stuttering without necessarily slowing down speech.126910
Research Team
Amanda Hampton Wray, PhD, CCC-SLP
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for children who stutter without other communication disorders, speak English primarily, and have typical language and cognitive abilities. They must not have a family history of stuttering (for non-stutterers), no metal implants, not be on neural-altering meds, nor pregnant. MRI contraindications apply.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including standardized tests for speech, language, and cognitive skills
Experimental Tasks
Participants complete EEG and fMRI tasks to evaluate neural processing of speech signals
Follow-up
Participants are monitored for any delayed effects or additional data collection
Treatment Details
Interventions
- Speech sound stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
University of Michigan
Collaborator